2048 Ventures, LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- Website
- https://2048.vc
- HQ
- NJ
2048 Ventures, LLC invests at the earliest stages, favoring systems of record and businesses where data compounds into durable moats. Its focus areas are AI, Deep Tech, Health, and Bio. The firm's team includes Alex Iskold, Founder and Partner, Zann Ali, Partner, and Daniella Cohen, Principal. Portfolio company Immunara is building frontier AI for immunology.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Pre-seed, Seed | Not enough dated deals |
| Sectors | Healthtech, Biotech | Not enough dated deals |
| Regions | US, MA, NY | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| 2048 Ventures III, LP 2048 Ventures invests at the earliest stages, leading or following pre-seed and seed rounds. It favors systems of record and businesses where data compounds into durable moats, across AI, Deep Tech, Health, and Bio. Inferred from the firm's website | 2025 | $82.05M (Form D) | Open, writing first checks |
| 2048 Ventures II, LP 2048 Ventures invests at the earliest stages, leading or following pre-seed and seed rounds. It favors systems of record and businesses where data compounds into durable moats, across AI, Deep Tech, Health, and Bio. Inferred from the firm's website | 2022 | $66.23M (Form D) | Late investment period |
03 · People across funds
- Alex Iskold, Founder and Partner
2048 Ventures III, LP (Named on Form D); 2048 Ventures II, LP (Named on Form D)
- Daniella Cohen, Principal
2048 Ventures III, LP (Team); 2048 Ventures II, LP (Team)
- Zann Ali, Partner
2048 Ventures III, LP (Team); 2048 Ventures II, LP (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026